Cargando…
Resistance to Antimalarial Monotherapy Is Cyclic
Malaria is a prevalent parasitic disease that is estimated to kill between one and two million people—mostly children—every year. Here, we query PubMed for malaria drug resistance and plot the yearly citations of 14 common antimalarials. Remarkably, most antimalarial drugs display cyclic resistance...
Autores principales: | Weitzman, Rachel, Calfon-Peretz, Ortal, Saha, Trishna, Bloch, Naamah, Ben Zaken, Karin, Rosenfeld, Avi, Amitay, Moshe, Samson, Abraham O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836566/ https://www.ncbi.nlm.nih.gov/pubmed/35160232 http://dx.doi.org/10.3390/jcm11030781 |
Ejemplares similares
-
Reply to van der Pluijm et al. Comment on “Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781”
por: Calfon-Peretz, Ortal, et al.
Publicado: (2022) -
Autoimmune Disease Classification Based on PubMed Text Mining
por: Samuels, Hadas, et al.
Publicado: (2022) -
Towards a Consensus on Alzheimer’s Disease Comorbidity?
por: Avitan, Iska, et al.
Publicado: (2021) -
Comment on Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781
por: van der Pluijm, Rob W., et al.
Publicado: (2022) -
Virtual Screening for FDA-Approved Drugs That Selectively Inhibit Arginase Type 1 and 2
por: Detroja, Trishna Saha, et al.
Publicado: (2022)